Skip to main content
. 2016 Aug 11;8(1):214–222. doi: 10.1039/c6sc01461e

Fig. 5. Cell viability of endometrial cancer HEC-1-B cells treated with peptide TAT-NLS-CKTCNGSATLCTSCPK-NH2 for 24 h, 48 h, and 72 h, respectively. Each value represents the average value from three independent experiments.

Fig. 5